Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLS-1200 for SARS-CoV-2 prevention
NCT04408183Phase 2Terminated
- Sponsor
- GeneOne Life Science, Inc.
- Start
- Jun 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quinine in coronavirus disease 2019 (COVID-19), sponsored by GeneOne Life Science, Inc.. Started Jun 2020; status: terminated.
02
Drugs
quinine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04408183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04408183.